US Food and Drug Administration (FDA)

New treatment for patients with drug-resistant epilepsy

Barrow Neurological Institute is the first Arizona hospital to offer a new treatment for patients with drug-resistant epilepsy.

FDA approves first continuous glucose monitoring system

The US Food and Drug Administration has approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip.

Raiing Medical Company

Raiing make temperature-sensing electronic skin patches for fertility tracking.

Second Sight Medical Products, Inc.

In this profile, Dr. Alexis Karandrea interviews Dr. Robert Greenberg, Chairman of the Board for Second Sight Medical Products, to learn more about their technologies and future directions.

Pixium Vision

In this profile Alexis Karandrea interviews Mr. Didier Laurens, the Chief Financial Officer of Pixium Vision, on their IRIS and PRIMA retinal implant technologies.

Next generation spinal cord stimulator for chronic pain

Neurostimulation therapy for chronic intractable pain uses a medical device placed under a patient's skin to deliver mild electrical impulses through a lead implanted in the epidural space to block pain signals from going to the brain.

One vaccine injection could carry many doses

Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.

Sensars Neuroprosthetics grabs government funding for disruptive tech

European Commission's Horizon 2020 SME (small-medium sized enterprises) Instrument recently announced Sensars Neuroprosthetics as a Phase 1 recipient for funding of their SENSY technology. Phase 1 recipients receive €50000 in funding for 6 months to execute a feasibility study and draft a 10-page business proposal. This is intended to bring the technology from the idea to concept stage. There are currently 2813 participants, 2750 projects coordinated, and 1094,87M€ allocated to the Horizon 2020 SME Instrument.

Using ultrasound to trigger on-demand, site-specific pain relief

A novel system uses ultrasound to trigger the release of nerve-blocking agents — injected into specific sites of the body ahead of time — when and where pain relief is needed most.

University of Florida performs its first retinal implant

The University of Florida performs its first retinal implant with the Argus II by Second Sight. The Argus II is an epiretinal implant consisting of an inner electrode array placed in the eye where it can stimulate the remaining cells in the retina, effectively taking the place of the rod and cone cells that have died off due to degenerative retinal diseases like retinitis pigmetosa.

Cellf BIO LLC

IDTechEx analyst Nadia Tsao interviewed Cellf BIO Founder Prof Khalil Bitar and COO Rayana Marker on July 27, 2017. Cellf BIO is a tissue engineering company producing bioengineered sphincters to address the root cause of fecal incontinence.

Towards a high-resolution, implantable neural interface

The goal of The Neural Engineering System Design program is developing an implantable system able to provide precision communication between the brain and the digital world.

CorTec GmbH

In this profile, Alexis Karandrea interviews Christina Schwartz to learn more about CorTec and the innovative technologies they offer and are developing for the research and clinical settings.

VNS therapy receives FDA approval for expanded MRI labeling

More than one in three people with epilepsy has drug-resistant seizures, meaning seizures persist in spite of treatment with antiepileptic medications.

A noninvasive method for deep brain stimulation

Researchers have come up with a way to stimulate regions deep within the brain using electrodes placed on the scalp.

ElectroMedical Technologies international reach for bioelectronics

The WellnessPro line of products represents the industry's first intelligent portable bioelectronic platform, which unlike conventional TENS devices, delivers faster, lasting pain relief based on a proprietary DeepPulse™ technology.

Stimwave wins contract with Defense Logistics Agency

Stimwave's devices use Wireless Pain Relief technology and are 95 percent smaller than any other neuromodulation device on the market.

First non-invasive vagus nerve stimulation therapy for acute pain

The U.S. Food and Drug Administration released the use of gammaCore® (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients.

Bionic Eye Technologies

In this profile, Alexis Karandrea reports on correspondence with Richard Birney, the CEO of Bionic Eye Technologies, Inc., and the retinal implant technology they are developing.

Retina Implant AG

In this profile Alexis Karandrea interviews Juergen Klein discussing the company's subretinal implant technology.